Literature DB >> 26261764

Blunted perception of dyspnea in asthmatic children: A potential misleading criterion.

Konstantinos Douros1, Barbara Boutopoulou1, Kostas N Priftis1.   

Abstract

Dyspnea (or breathlessness) is a symptom describing a perceived experience of breathing discomfort. Children's awareness of dyspnea is variable and there is only a poor correlation between the objective respiratory distress measurements and the subjectively awareness of dyspnea. Those who do not perceive dyspnea may not be motivated to comply with their daily prophylactic treatment. Since dyspnea is the main symptom of asthma, and disease management is based largely on the description of symptoms between clinic visits, unreliable symptom report may mislead decision-making for long-term treatment of asthma. Thus, therapeutic decisions should not be taken solely on patients' perception and description of dyspnea.

Entities:  

Keywords:  Asthma; Breathlessness; Respiratory distress; Symptom; Tachypnea

Year:  2015        PMID: 26261764      PMCID: PMC4526836          DOI: 10.5409/wjcp.v4.i3.38

Source DB:  PubMed          Journal:  World J Clin Pediatr        ISSN: 2219-2808


  12 in total

1.  Excessive breathlessness through emotional imagery in asthma.

Authors:  S Rietveld; W Everaerd; I van Beest
Journal:  Behav Res Ther       Date:  2000-10

2.  Symptom perception in childhood asthma: the role of anxiety and asthma severity.

Authors:  Edith Chen; Cathy Hermann; Denise Rodgers; Tina Oliver-Welker; Robert C Strunk
Journal:  Health Psychol       Date:  2006-05       Impact factor: 4.267

3.  Children's perception of breathlessness in acute asthma.

Authors:  I Male; H Richter; P Seddon
Journal:  Arch Dis Child       Date:  2000-10       Impact factor: 3.791

4.  Perceived exertion as an indicator of somatic stress.

Authors:  G Borg
Journal:  Scand J Rehabil Med       Date:  1970

5.  The perception of breathlessness in asthma.

Authors:  J G Burdon; E F Juniper; K J Killian; F E Hargreave; E J Campbell
Journal:  Am Rev Respir Dis       Date:  1982-11

6.  An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea.

Authors:  Mark B Parshall; Richard M Schwartzstein; Lewis Adams; Robert B Banzett; Harold L Manning; Jean Bourbeau; Peter M Calverley; Audrey G Gift; Andrew Harver; Suzanne C Lareau; Donald A Mahler; Paula M Meek; Denis E O'Donnell
Journal:  Am J Respir Crit Care Med       Date:  2012-02-15       Impact factor: 21.405

Review 7.  Dyspnea: the role of psychological processes.

Authors:  Steven De Peuter; Ilse Van Diest; Valentine Lemaigre; Geert Verleden; Maurits Demedts; Omer Van den Bergh
Journal:  Clin Psychol Rev       Date:  2004-09

8.  Perception of exercise induced asthma by children and their parents.

Authors:  S Panditi; M Silverman
Journal:  Arch Dis Child       Date:  2003-09       Impact factor: 3.791

9.  Perception of bronchoconstriction: a complementary disease marker in children with asthma.

Authors:  Marianne Nuijsink; Wim C J Hop; Johan C de Jongste; Peter J Sterk; And Eric J Duiverman
Journal:  J Asthma       Date:  2013-05-20       Impact factor: 2.515

10.  Poor perception of dyspnoea in children with undiagnosed asthma.

Authors:  R van Gent; L E M van Essen-Zandvliet; M M Rovers; J L L Kimpen; G de Meer; C K van der Ent
Journal:  Eur Respir J       Date:  2007-07-25       Impact factor: 16.671

View more
  2 in total

1.  Telehome Monitoring of Symptoms and Lung Function in Children with Asthma.

Authors:  Audrey Fossati; Caroline Challier; Aman Allah Dalhoumi; Javier Rose; Annick Robinson; Caroline Perisson; François Galode; Baptiste Luaces; Michael Fayon
Journal:  Healthcare (Basel)       Date:  2022-06-17

2.  Optimising telephone triage of patients calling for acute shortness of breath during out-of-hours primary care: protocol of a multiple methods study (Opticall).

Authors:  Michelle Spek; Roderick Venekamp; Esther De Groot; Geert-Jan Geersing; Daphne Carmen Erkelens; Maarten van Smeden; Frans H Rutten; Dorien L Zwart
Journal:  BMJ Open       Date:  2022-04-21       Impact factor: 3.006

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.